Welcome
Support Centre
16 September 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Home-based voluntary human immunodeficiency virus (HIV) counselling and testing in Zambia
ISRCTN ISRCTN53353725
DOI 10.1186/ISRCTN53353725
ClinicalTrials.gov identifier
EudraCT number
Public title Home-based voluntary human immunodeficiency virus (HIV) counselling and testing in Zambia
Scientific title A community randomised trial on acceptability, feasibility, preventive impact and cost effectiveness of home-based voluntary human immunodeficiency virus (HIV) counselling and testing in Zambia
Acronym N/A
Serial number at source N/A
Study hypothesis Home-based voluntary human immunodeficiency virus (HIV) counselling and testing is more acceptable and gives higher uptake than clinic-based voluntary counselling and testing.
Lay summary
Ethics approval 1. University of Zambia Research Ethics Committee gave approval on the 26th March 2009 (ref: 007-12-08)
2. Regional Ethical Committee of Western Norway gave approval on the 26th February 2009 (ref: 024.09)
Study design Community-randomised controlled trial
Countries of recruitment Zambia
Disease/condition/study domain Human immunodeficiency virus (HIV)
Participants - inclusion criteria Household members (either sex) aged 16 years and above in the 28 selected villages
Participants - exclusion criteria 1. Aged below 16 years
2. Not ordinary household members
3. People without full mental capacity
4. People under influence of alcohol or illegal drugs
Anticipated start date 23/03/2009
Anticipated end date 31/12/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 1400
Interventions A baseline survey will be conducted in 28 villages. 14 villages will be randomised to intervention (home-based voluntary HIV counselling and testing [VCT]) and a follow up survey will be conducted in both intervention and control villages after 6 months.
Primary outcome measure(s) Uptake and acceptability of VCT, measured at baseline and with follow-up surveys.
Secondary outcome measure(s) Changes in sexual risk behaviour, stigma and life-events, measured at baseline and with follow-up surveys.
Sources of funding Swedish International Development Cooperation Agency (SIDA) (Sweden)
Trial website
Publications
Contact name Dr  Charles  Michelo
  Address University of Zambia
School of Medicine
Department of Community Medicine
PO BOX 50110
  City/town Lusaka
  Zip/Postcode PO BOX 50110
  Country Zambia
  Email ccmichelo@yahoo.com
Sponsor Swedish International Development Cooperation Agency (SIDA) (Sweden)
  Address Valhallavägen 199
  City/town Stockholm
  Zip/Postcode 105 25
  Country Sweden
  Sponsor website: http://www.sida.org
Date applied 19/03/2009
Last edited 30/04/2009
Date ISRCTN assigned 30/04/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.